Literature DB >> 24669310

The future of Radiation Oncology: Considerations of Young Medical Doctor.

Bartosz Urbański1.   

Abstract

Radiation therapy plays an increasingly important role in the management of cancer. Currently, more than 50% of all cancer patients can expect to receive radiotherapy during the course of their disease, either in a primary management (radical or adjuvant radiotherapy) or for symptom control (palliative radiotherapy). Radiation oncology is a very unique branch of medicine connected with clinical knowledge and also with medical physics. In recent years, this approach has become increasingly absorbed with technological advances. This increasing emphasis on technology, together with other important changes in the health-care economic environment, now place the specialty of radiation oncology in a precarious position. New treatment technologies are evolving at a rate unprecedented in radiation therapy, paralleled by improvements in computer hardware and software. These techniques allow assessment of changes in the tumour volume and its location during the course of therapy (interfraction motion) so that re-planning can adjust for such changes in an adaptive radiotherapy process. If radiation oncologists become simply the guardians of a single therapeutic modality they may find that time marches by and, while the techniques will live on, the specialty may not. This article discusses these threats to the field and examines strategies by which we may evolve, diversify, and thrive.

Entities:  

Keywords:  Challenges; Perspectives; Radiation oncology

Year:  2012        PMID: 24669310      PMCID: PMC3885896          DOI: 10.1016/j.rpor.2012.09.002

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  29 in total

1.  An overview of hypofractionation and introduction to this issue of seminars in radiation oncology.

Authors:  Robert D Timmerman
Journal:  Semin Radiat Oncol       Date:  2008-10       Impact factor: 5.934

2.  Recent developments in brachytherapy.

Authors:  Ferran Guedea
Journal:  Rep Pract Oncol Radiother       Date:  2011-12-04

3.  12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer.

Authors:  Louis Potters; Carol Morgenstern; Emil Calugaru; Paul Fearn; Anup Jassal; Joseph Presser; Edward Mullen
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

4.  Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer.

Authors:  J A Hayman; B E Hillner; J R Harris; J C Weeks
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

5.  Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate?

Authors:  Andre Konski; William Speier; Alexandra Hanlon; J Robert Beck; Alan Pollack
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544

6.  Current status and future potential of advanced technologies in radiation oncology. Part 2. State of the science by anatomic site.

Authors:  Bhadrasain Vikram; C Norman Coleman; James A Deye
Journal:  Oncology (Williston Park)       Date:  2009-04-15       Impact factor: 2.990

Review 7.  Current status and future potential of advanced technologies in radiation oncology. Part 1. Challenges and resources.

Authors:  Bhadrasain Vikram; C Norman Coleman; James A Deye
Journal:  Oncology (Williston Park)       Date:  2009-03       Impact factor: 2.990

Review 8.  Cyberknife: A double edged sword?

Authors:  Bindhu Joseph; Sanjay S Supe; Aruna Ramachandra
Journal:  Rep Pract Oncol Radiother       Date:  2010-07-06

9.  PET/CT staging followed by Intensity-Modulated Radiotherapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: a matched-pair comparison.

Authors:  Sacha Rothschild; Gabriela Studer; Burkhardt Seifert; Pia Huguenin; Christoph Glanzmann; J Bernard Davis; Urs M Lütolf; Thomas F Hany; I Frank Ciernik
Journal:  Radiat Oncol       Date:  2007-06-09       Impact factor: 3.481

10.  Problems and solutions in calculating quality-adjusted life years (QALYs).

Authors:  Luis Prieto; José A Sacristán
Journal:  Health Qual Life Outcomes       Date:  2003-12-19       Impact factor: 3.186

View more
  4 in total

1.  Novel drugs in pediatric gliomas.

Authors:  Dongli Zhang; Xiaoming Liu; Conghai Fan; Jiao Chen
Journal:  Oncol Lett       Date:  2017-03-06       Impact factor: 2.967

2.  Establishment and characterization of a radiation-induced dermatitis rat model.

Authors:  Xiaowu Sheng; Yue Zhou; Hui Wang; Yongyi Shen; Qianjin Liao; Zhen Rao; Feiyan Deng; Luyuan Xie; Chaoling Yao; Huangxing Mao; Zhiyan Liu; Mingjing Peng; Ying Long; Yong Zeng; Lei Xue; Nina Gao; Yu Kong; Xiao Zhou
Journal:  J Cell Mol Med       Date:  2019-02-28       Impact factor: 5.310

3.  Pregnancy screening practices and treatment of pregnant patients among radiation oncologists: results of an international survey.

Authors:  Peter Zaki; Junjia Zhu; Heath B Mackley; Jennifer C Rosenberg
Journal:  Ecancermedicalscience       Date:  2021-01-13

4.  Master of Science (MSc) Program in Radiation Biology: An Interdepartmental Course Bridging the Gap between Radiation-Related Preclinical and Clinical Disciplines to Prepare Next-Generation Medical Scientists.

Authors:  Stephanie E Combs; Carmen Kessel; Jan J Wilkens; Gabriele Multhoff; Thomas E Schmid; Peter Vaupel; Klaus-Rüdiger Trott; Pascal Berberat; Michael J Atkinson
Journal:  Front Oncol       Date:  2017-09-22       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.